NEA Management Company as of March 31, 2025
Portfolio Holdings for NEA Management Company
NEA Management Company holds 38 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcellx Common Stock (ACLX) | 18.9 | $246M | 3.7M | 65.60 | |
| Verona Pharma Sponsered Ads (VRNA) | 13.1 | $171M | 2.7M | 63.49 | |
| Rhythm Pharmaceuticals (RYTM) | 11.9 | $154M | 2.9M | 52.97 | |
| Tempus Ai Cl A (TEM) | 9.7 | $126M | 2.6M | 48.24 | |
| Coursera (COUR) | 6.6 | $86M | 13M | 6.66 | |
| Trevi Therapeutics (TRVI) | 5.5 | $72M | 11M | 6.29 | |
| Savara (SVRA) | 5.2 | $68M | 25M | 2.77 | |
| Crispr Therapeutics Namen Akt (CRSP) | 4.2 | $54M | 1.6M | 34.03 | |
| Monte Rosa Therapeutics (GLUE) | 2.7 | $36M | 7.7M | 4.64 | |
| Aurinia Pharmaceuticals (AUPH) | 2.5 | $32M | 4.0M | 8.04 | |
| Mbx Biosciences (MBX) | 2.1 | $27M | 3.6M | 7.38 | |
| CVRX (CVRX) | 1.9 | $25M | 2.0M | 12.23 | |
| Zenas Biopharma (ZBIO) | 1.6 | $21M | 2.6M | 7.90 | |
| Gossamer Bio (GOSS) | 1.5 | $20M | 18M | 1.10 | |
| Korro Bio (KRRO) | 1.5 | $19M | 1.1M | 17.41 | |
| Neuehealth Com New | 1.4 | $18M | 2.7M | 6.76 | |
| Champions Oncology Com New (CSBR) | 1.1 | $15M | 1.7M | 8.68 | |
| Senti Biosciences Com New (SNTI) | 1.0 | $13M | 3.8M | 3.36 | |
| Celcuity (CELC) | 1.0 | $13M | 1.3M | 10.11 | |
| Phathom Pharmaceuticals (PHAT) | 0.9 | $12M | 2.0M | 6.27 | |
| Oric Pharmaceuticals (ORIC) | 0.9 | $12M | 2.2M | 5.58 | |
| Regulus Therapeutics | 0.9 | $11M | 6.5M | 1.75 | |
| Desktop Metal Com Cl A (DM) | 0.5 | $7.1M | 1.4M | 4.91 | |
| Black Diamond Therapeutics (BDTX) | 0.5 | $6.9M | 4.4M | 1.55 | |
| Nkarta (NKTX) | 0.5 | $6.6M | 3.6M | 1.84 | |
| Buzzfeed Cl A New (BZFD) | 0.4 | $5.4M | 2.5M | 2.13 | |
| Inventiva Sa Ads (IVA) | 0.3 | $4.3M | 1.5M | 2.94 | |
| Synlogic Com New (SYBX) | 0.3 | $3.6M | 2.9M | 1.24 | |
| X4 Pharmaceuticals | 0.3 | $3.5M | 15M | 0.24 | |
| Adaptimmune Therapeutics Sponds Adr (ADAPY) | 0.3 | $3.4M | 17M | 0.20 | |
| Inozyme Pharma (INZY) | 0.2 | $2.2M | 2.4M | 0.91 | |
| Onkure Therapeutics Com Cl A (OKUR) | 0.2 | $2.1M | 479k | 4.30 | |
| Marker Therapeutics Com New (MRKR) | 0.2 | $2.0M | 1.6M | 1.23 | |
| Allakos | 0.1 | $1.4M | 6.1M | 0.23 | |
| Ikena Oncology (IKNA) | 0.1 | $768k | 600k | 1.28 | |
| Affimed N V Ordinary Shs New (AFMDQ) | 0.0 | $320k | 443k | 0.72 | |
| Wheels Up Experience Com Cl A (UP) | 0.0 | $107k | 106k | 1.01 | |
| Tuya Sponsered Ads (TUYA) | 0.0 | $0 | 0 | 0.00 |
